Six-in-One Combination Vaccine for Infant Immunisation

A hexavalent vaccine protects against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Haemophilus influenzae type b disease within a single injection. Combining these antigens reduces the total number of injections an infant requires to complete primary immunisation. This can improve caregiver acceptance and support timely completion of the vaccination schedule. Each component antigen provides protection equivalent to its corresponding standalone vaccine.

Combination vaccines reduce injection burden, simplify scheduling and can improve on-time completion of infant immunisation series compared with separate individual vaccines. Fewer injections per visit may also reduce caregiver anxiety and clinic visit numbers. Immunogenicity and safety profiles of combination vaccines are established through clinical trials evaluating each antigen component. These benefits support their inclusion in national immunisation programmes in many countries.

Hexavalent vaccine administration follows a multi-dose primary series schedule during infancy, with exact timing determined by national immunisation programme guidelines. Doses are generally spaced according to standard infant vaccination intervals to build adequate immunity. Catch-up scheduling may apply for infants who present later than the standard schedule. Healthcare professionals should confirm current dosing intervals against South African immunisation programme guidance.